Fasting Glucose

Fasting glucose (also called fasting blood glucose, FBG, or fasting blood sugar, FBS) measures the amount of glucose (blood sugar) circulating in your bloodstream after you have fasted for at least 8 hours, usually first thing in the morning. Glucose is your body’s primary fuel source, and your brain relies heavily on glucose to function. After you eat, carbohydrates are broken down into glucose, which enters your blood. Your pancreas then releases insulin, a hormone that acts like a “key” to help move glucose out of the bloodstream and into your cells for energy use or storage. When you are fasting, your body still needs a steady supply of glucose — so your liver releases stored glucose to keep blood sugar stable and ensure your brain and vital organs have continuous fuel.

Your fasting glucose level reflects how well your body maintains this balance between glucose production (mainly from the liver) and glucose clearance (mainly through insulin action). In healthy individuals, fasting glucose typically falls around 74–99 mg/dL (4.1–5.5 mmol/L). When fasting glucose rises to 100–125 mg/dL, this is considered prediabetes, specifically impaired fasting glucose (IFG). A fasting glucose of 126 mg/dL or higher on two separate occasions indicates diabetes. These cut-offs were established because at and above these levels, the risk of long-term complications — especially affecting the eyes (retinopathy), kidneys (nephropathy), and cardiovascular system — increases meaningfully.

Maintaining balanced glucose levels is essential for stable energy, mood, and long-term metabolic health. When blood sugar rises, insulin helps move glucose into cells. When it drops, the hormone glucagon releases stored glucose from the liver. However, modern diets high in refined carbohydrates and sugars can overwhelm this system — leading to insulin resistance, prediabetes, or type 2 diabetes.

Chronically high glucose levels (hyperglycemia) trigger excess insulin production, pushing unused glucose into fat cells and promoting visceral (“belly”) fat accumulation. Over time, this drives inflammation, fatigue, and weight gain. On the other hand, very low glucose (hypoglycemia) can cause shakiness, dizziness, sweating, and confusion.

Even within the “normal” range, studies show cardiovascular risk begins to rise once fasting glucose exceeds 85 mg/dL, underscoring how tight control of blood sugar supports longevity and disease prevention.

Dietary factors

Diet strongly influences fasting glucose through effects on insulin sensitivity and overall metabolic load. Diets high in saturated fat are associated with higher fasting glucose and reduced insulin sensitivity, while polyunsaturated fats (PUFAs) — from foods like fatty fish, walnuts, and flaxseeds — are associated with lower fasting glucose and improved insulin function. Nutrient patterns higher in dietary fibre, whole grains, and B vitamins are linked with lower fasting glucose and HbA1c (average glucose over 2–3 months). In contrast, dietary patterns high in red and processed meat, refined carbohydrates, sweets, sugary beverages, and fried foods are associated with higher fasting glucose. Long-term data also show that increasing adherence to a “red meat” dietary pattern from youth into adulthood is associated with higher impaired fasting glucose risk, partly explained by lower fibre intake. Overall, dietary quality — focusing on whole grains, legumes, nuts, fruits, vegetables, and minimally processed foods — is consistently associated with better glucose regulation and lower diabetes risk.

Lifestyle factors

Lifestyle has large leverage on fasting glucose. Physical activity is protective: achieving 150 minutes per week of moderate-intensity activity (like brisk walking) reduces diabetes incidence meaningfully — even without weight loss. Weight loss of 7% or more is one of the strongest predictors of fasting glucose improvement and reduced progression to diabetes. Sleep and stress also influence glucose regulation. Meal timing (later eating occasions and prolonged eating windows) can affect glucose variability, and effects may differ depending on whether someone already has dysglycaemia. Fasting and energy-restricting diets have been shown to reduce fasting glucose, insulin, and insulin resistance, with stronger reductions in people who are overweight or obese, especially with interventions lasting longer than 8 weeks.

Related biomarkers and body systems

Fasting glucose is best interpreted alongside complementary markers: HbA1c (2–3 month average), fasting insulin, and HOMA-IR (an estimate of insulin resistance). Broader cardiometabolic markers often travel with glucose changes, including triglycerides, HDL cholesterol, and liver enzymes (e.g., ALT/AST), reflecting interconnected liver–metabolic pathways.

Micronutrients and environmental influences

Micronutrient status can influence glucose metabolism. Deficiencies in vitamin D, magnesium, zinc, and chromium are associated with impaired glucose regulation. Environmental and behavioural contributors include alcohol, smoking, certain medications, chronic stress, inadequate sleep, and socioeconomic factors such as food insecurity and low income, which can shape diet quality and metabolic risk patterns over time.

If your results are high

If your fasting glucose is elevated (100–125 mg/dL = prediabetes; ≥126 mg/dL on two occasions = diabetes), nutrition and lifestyle changes are the cornerstone.

Diet:

• Adopt a whole-food, minimally processed pattern with a focus on lowering saturated fat intake (especially if weight loss is needed).

• Aim for 2–3 servings of fatty fish per week (salmon, mackerel, sardines).

• Target 25–30 g of fibre daily from oats, barley, legumes, vegetables, and fruits.

• Choose whole grains over refined carbohydrates, and limit or eliminate sugary beverages, sweets, fried foods, and processed meats.

• Keep red meat to no more than 1–2 servings per week.

• Dietary patterns such as Mediterranean-style, DASH, or plant-based approaches are associated with lower diabetes risk.

Lifestyle:

• If you are overweight or obese, aim for ≥7% weight loss, as this threshold is associated with major reductions in diabetes progression risk.

• Complete at least 150 minutes per week of moderate-intensity activity, spread across most days.

• Prioritise 7–9 hours of sleep nightly, manage stress using relaxation or mindfulness techniques, and limit alcohol.

Supplements:

• Supplements with evidence for glycaemic support include vitamin D (1000–4000 IU daily, adjusted to blood levels), magnesium (300–400 mg daily), zinc (15–30 mg daily, e.g., glycinate or gluconate), and chromium (200–1000 mcg daily).

• Other options with supportive but lower-certainty evidence include vitamin C (500–1000 mg daily), omega-3s (1–2 g EPA/DHA daily), and cinnamon (1–6 g daily).

• Evidence quality varies, and individual needs differ — medical guidance is recommended.

Additional tests:

• HbA1c

• fasting insulin and HOMA-IR

• lipid panel (including triglycerides and HDL)

• liver enzymes (ALT/AST)

• kidney function (creatinine

• eGFR)

• micronutrient status such as vitamin D and magnesium. Screening for thyroid function and coeliac disease may be considered if clinically indicated

If your results are low

If your fasting glucose is low, the goal is to support steadier glucose availability and reduce symptomatic episodes — especially if symptoms occur.

Diet:

• Use balanced meals and snacks every 3–4 hours when needed, combining complex carbohydrates + protein + healthy fats for slower energy release.

• Include whole grains (e.g., oats, brown rice, quinoa), lean proteins (poultry, fish, legumes, eggs), and healthy fats (nuts, seeds, avocado, olive oil).

• Avoid skipping meals, particularly breakfast.

• Limit or avoid alcohol, especially on an empty stomach, because alcohol can reduce the liver’s ability to release glucose.

• Reduce refined carbohydrates and sugary foods that can cause rapid spikes followed by “crashes.” Smaller, more frequent meals may help if symptoms occur after eating.

Lifestyle:

• Watch for hypoglycaemia symptoms such as shakiness, sweating, confusion, dizziness, rapid heartbeat, and hunger, and keep a quick-acting carbohydrate option available if episodes occur.

• Exercise can lower glucose; consider a small snack before prolonged or intense activity.

• Keep meal timing consistent and avoid prolonged fasting.

Supplements:

• Supplements are generally not indicated unless a deficiency is identified.

• If endocrine conditions such as adrenal insufficiency or hypothyroidism are present, management should occur under medical supervision.

Additional tests:

• If recurrent or significant symptoms occur

• evaluation may include supervised fasting or mixed-meal testing

• blood-work during an episode (glucose

• insulin

• C-peptide

• proinsulin

• beta-hydroxybutyrate

• free fatty acids

• cortisol

• growth hormone

• medication screening)

• plus assessment of liver

• kidney

• adrenal

• thyroid

• coeliac status where clinically indicated. Medical supervision is essential for recurrent or severe hypoglycaemia

1. Sacks DB, Arnold M, Bakris GL, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2023;46(10):e151–e199. doi:10.2337/dci23-0036.

2. Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and Management of Prediabetes: A Review. JAMA. 2023;329(14):1206–1216. doi:10.1001/jama.2023.4063.

3. American Diabetes Association. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S27–S49. doi:10.2337/dc25-S002.

4. American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care. 2003;26(Suppl 1):S21–S24. doi:10.2337/diacare.26.2007.s21.

5. Dagogo-Jack S. Pathobiology of Prediabetes: Understanding and Interrupting Progressive Dysglycemia and Associated Complications. Diabetes. 2025;dbi250006. doi:10.2337/dbi25-0006.

6. Sorkin JD, Muller DC, Fleg JL, Andres R. The Relation of Fasting and 2-H Postchallenge Plasma Glucose Concentrations to Mortality. Diabetes Care. 2005;28(11):2626–2632. doi:10.2337/diacare.28.11.2626.

7. Guess N, Perreault L, Kerege A, Strauss A, Bergman BC. Dietary Fatty Acids Differentially Associate With Fasting Versus 2-Hour Glucose Homeostasis. PLoS One. 2016;11(3):e0150148. doi:10.1371/journal.pone.0150148.

8. Chikowore T, Pisa PT, van Zyl T, et al. Nutrient Patterns Associated With Fasting Glucose and Glycated Haemoglobin Levels. Nutrients. 2017;9(1):E9. doi:10.3390/nu9010009.

9. Nettleton JA, Hivert MF, Lemaitre RN, et al. Healthy Diet Associations With Fasting Glucose and Insulin Levels: Meta-analysis Across 15 Cohorts. Am J Epidemiol. 2013;177(2):103–115. doi:10.1093/aje/kws297.

10. Wu F, Pahkala K, Juonala M, et al. Dietary Pattern Trajectories From Youth to Adulthood and Adult Risk of Impaired Fasting Glucose. J Clin Endocrinol Metab. 2021;106(5):e2078–e2086. doi:10.1210/clinem/dgab044.

11. American Diabetes Association. 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S50–S58. doi:10.2337/dc25-S003.

12. Santos-Báez LS, Díaz-Rizzolo DA, Popp CJ, et al. Diet and Meal Pattern Determinants of Glucose Levels and Variability. Nutrients. 2024;16(9):1295. doi:10.3390/nu16091295.

13. Fatahi S, Nazary-Vannani A, Sohouli MH, et al. Fasting and Energy Restricting Diets and Markers of Glucose/Insulin Control: Systematic Review and Meta-analysis. Crit Rev Food Sci Nutr. 2021;61(20):3383–3394. doi:10.1080/10408398.2020.1798350.

14. An P, Wan S, Luo Y, et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. J Am Coll Cardiol. 2022;80(24):2269–2285. doi:10.1016/j.jacc.2022.09.048.

15. Xia J, Yu J, Xu H, et al. Comparative Effects of Vitamin and Mineral Supplements in Type 2 Diabetes: Systematic Review and Network Meta-analysis. Pharmacol Res. 2023;188:106647. doi:10.1016/j.phrs.2023.106647.

16. Kazemi A, Ryul Shim S, Jamali N, et al. Nutritional Supplements for Glycemic Control: Systematic Review and Network Meta-analysis. Diabetes Res Clin Pract. 2022;191:110037. doi:10.1016/j.diabres.2022.110037.

17. American Diabetes Association. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S128–S145. doi:10.2337/dc25-S006.

18. Fong C, Alesi S, Mousa A, et al. Nutrient Supplements for Glycaemic Control and Insulin Resistance: Umbrella Review. Nutrients. 2022;14(11):2295. doi:10.3390/nu14112295.

19. Hekmat-Ardakani A, Morshed-Behbahani B, Rahimi-Ardabili H, et al. Dietary Supplements and Natural Products Targeting Glucose Levels: Overview. Crit Rev Food Sci Nutr. 2023;63(23):6138–6167. doi:10.1080/10408398.2022.2028716.

20. Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous Hypoglycemia: Diagnostic Evaluation and Management. Endocrine. 2016;53(1):47–57. doi:10.1007/s12020-016-0902-0.

21. Kittah NE, Vella A. Pathogenesis and Management of Hypoglycemia. Eur J Endocrinol. 2017;177(1):R37–R47. doi:10.1530/EJE-16-1062.

22. Virally ML, Guillausseau PJ. Hypoglycemia in Adults. Diabetes Metab. 1999;25(6):477–490.